Company intelligence / Profile preview

Gordon Pointe Capital

Naples, FL, USA

Ownership: Private
Development stage: Other

Overview

Gordon Pointe Acquisition Corp. is a special purpose acquisition company (SPAC) formed in 2017 to acquire or merge with businesses, originally focused on the financial services sector, particularly FinTech and related industries[1][3][7]. There is no evidence of activity or acquisitions in biotech, pharma, or healthcare. The company has been flagged as potentially delisted and may no longer be active[1].

Industry: Investors

Beyond the preview

Go deeper on Gordon Pointe Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gordon Pointe Capital.

Explore the full profile